Your browser doesn't support javascript.
loading
Targeting EML4-ALK gene fusion variant 3 in thyroid cancer.
Aydemirli, Mehtap Derya; van Eendenburg, Jaap D H; van Wezel, Tom; Oosting, Jan; Corver, Willem E; Kapiteijn, Ellen; Morreau, Hans.
Affiliation
  • Aydemirli MD; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Eendenburg JDH; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Wezel T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Oosting J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Corver WE; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kapiteijn E; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Morreau H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Endocr Relat Cancer ; 28(6): 377-389, 2021 05 11.
Article in En | MEDLINE | ID: mdl-33878728
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Type of study: Guideline Limits: Humans / Male Language: En Journal: Endocr Relat Cancer Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Type of study: Guideline Limits: Humans / Male Language: En Journal: Endocr Relat Cancer Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom